OTC · ONSS
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 6:32 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
ONSS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning ONSS.
ONSS research
Company profile and research snapshot.
ONASSIS HOLDINGS CORP
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Nov 5, 2025
Onassis Holdings Corp has appointed Paz Itzhaki-Weinberger to its Advisory Board to lead international law, trade, and cross-border corporate affairs. Itzhaki-Weinberger brings extensive experience in technology, law, and international business.
Benzinga · Sep 15, 2025
Onassis Holdings Corp, a biotech holding company, has partnered with Dalmore Group to launch a Regulation A+ financing round to raise up to $75 million from public investors, focusing on longevity and rejuvenation technologies.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ONSS.
No results
No recent SID articles mention ONSS.
